Tiziana Life Sciences announced positive preclinical results for their intranasal anti-CD3 monoclonal antibody, foralumab, in treating traumatic spinal cord...

MiNK Therapeutics announced a presentation at the ASCO GI Symposium detailing a Phase 2 trial of its iNKT cell...

Outlook Therapeutics presented 12-week data from its NORSE EIGHT clinical trial of ONS-5010 (bevacizumab-vikg) for wet age-related macular degeneration...

AIM ImmunoTech Inc. announced final clinical study results (AMP-518) for Ampligen in treating post-COVID conditions, specifically fatigue. The study,...

Quoin Pharmaceuticals announced further clinical evidence supporting the efficacy of QRX003, its topical treatment for Netherton Syndrome. Data from...

Exicure, Inc. acquired GPCR Therapeutics USA Inc. and entered into a licensing and collaboration agreement with GPCR Therapeutics Inc....

Segal Trials, a clinical research network specializing in psychiatric disorders, significantly contributed to the successful Phase 2 trial of...

ExThera Medical received funding from the Medical Technology Enterprise Consortium (MTEC) for a randomized controlled trial. The trial will...

Vaxxas, a clinical-stage biotech company, is developing a heat-stable, dried-formulation mRNA vaccine delivered via its microarray patch (HD-MAP) with...

OKYO Pharma, a clinical-stage biopharmaceutical company developing treatments for neuropathic corneal pain (NCP) and dry eye disease (DED), has...